The combination of increased FGF23 and low Klotho – a FGF23 cofactor – levels is associated with a higher risk of cardiovascular death or heart failure (HF) hospitalization in subjects with stable ischemic heart disease. This evidence concerns the gene FGF23 and heart failure.